Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient

Authors not listed

Centre Hospitalier Universitaire de Besancon · 2014

Abstract

The aim of this study is to investigate the role of immunosenescence in the HBV vaccination response in patients with renal insufficiency.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
Anonymous. (2014). Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient. <em>Centre Hospitalier Universitaire de Besancon</em>. https://clinicaltrials.gov/study/NCT02375711
Vancouver
Anonymous. Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient. Centre Hospitalier Universitaire de Besancon. 2014.
BibTeX
@misc{anon2014Evalua, title = {Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient}, author = {Anonymous}, journal = {Centre Hospitalier Universitaire de Besancon}, year = {2014}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings